An ezine brought to you by AlternativeMentalHealth.com and Safe Harbor,
a nonprofit corporation.

Dan Stradford, Editor
Alan Graham, Assistant Editor
Gloria McTaggart, Research Editor
SafeHarborProj@aol.com
www.AlternativeMentalHealth.com

Feedback: We'd like to hear your comments and views. Please forward them
to the e-mail address above. Contact information is below.

Did someone forward this ezine to you? You can subscribe for yourself by
visiting our web site and using the sign-up form there, or just by
sending a blank e-mail to...

amh.10@add.postmastergeneral.com

Complete unsubscribing instructions are at the end of this message. Or,
you can reply to this message and ask to be removed from the list.

TABLE OF CONTENTS

* ABOUT SAFE HARBOR

* LETTER TO THE EDITOR

* ARTICLE: ACUPUNCTURE TAKES AIM AT DEPRESSION

* ARTICLE: FISH OIL FOUND EFFECTIVE AGAINST "BIPOLAR DISORDER"

* ARTICLE: MOOD-ALTERING DRUGS AND EDUCATIONAL PERFORMANCE

* ARTICLE: CONNECTICUT BILL FORBIDS SCHOOLS TO PROMOTE RITALIN

* ARTICLE: NEUROLOGICAL IMPACT OF FLUORIDE TOXICITY

* ARTICLE: B-12 AND FOLATE CAN REDUCE ALZHEIMER'S RISK

* ARTICLE: IS IT DEPRESSION, OR CHRONIC FATIGUE SYNDROME?

* ARTICLE: ORTHOMOLECULAR SUPPORTERS HOLD TORONTO EVENT

* ABOUT ALTERNATIVEMENTALHEALTH.COM

ABOUT SAFE HARBOR

Safe Harbor was founded in 1998 in the wake of growing public
dissatisfaction with the unwanted effects of orthodox psychiatric
treatments such as medication and shock therapy. Seeking to satisfy the
desire for safer, more effective treatments, the Project is dedicated to
educating the public, the medical profession, and government officials
on research and treatments that, minimally, do no harm and, optimally,
cure the causes of severe mental symptoms. Our primary thrust is
education on the medical causes of severe mental symptoms and the use of
nutritional and other natural treatments.

Contact info:
Safe Harbor
1718 Colorado Bl.
Los Angeles, California 90041
U.S.A.
(818) 890-1862
SafeHarborProj@aol.com
www.AlternativeMentalHealth.com

WE WELCOME YOUR DONATIONS. AS A NONPROFIT ORGANIZATION, SAFE HARBOR IS
SUPPORTED SOLELY THROUGH THE GENEROSITY OF THE PUBLIC. DONATIONS CAN
BE MAILED TO THE ABOVE ADDRESS. WE ALSO ACCEPT VISA/MASTERCARD BY
PHONE. THANK YOU.

LETTER TO THE EDITOR

top

You are doing a great job with this newsletter. By the way, most of
these anxiety cases are suffering from a deficiency of Vitamin E2 (only
available in natural form). It is generally bought about through the
refined-food American diet which no longer includes excellent sources of
the whole vitamin E complex (like raw butter), or other high quality
vegetable sources like certain organic baby greens, sprouts, etc. all of
which can be home grown.

We handle "anxiety" routinely by getting patients to reduce their
processed food loads and taking "Cataplex E2" from Standard Process
Products (Palmyra), sometimes starting with 5 tablets or even more per
meal with adults, generally about a third as much or less with children
-- and gradually reducing to 1-2 per meal for extreme cases. Takes
anywhere from a few weeks to a few months. Depending on diet, they may
need the supplement for a long period of time. Works like a charm in
almost all cases.

Freddie Ulan, DC
Certified Clinical Nutritionist
Director, Natural Health Improvement Center
Glens Falls, NY 12801
518-745-7473
www.capital.net/com/nhic

ACUPUNCTURE TAKES AIM AT DEPRESSION

top

A pioneering pilot study, funded by the U.S. Office of Alternative
Medicine, suggests that acupuncture may offer surprising benefits for
those who are clinically depressed.

More therapeutic options would be welcome, experts say. Depression
reportedly costs Americans about $40 billion a year in lost productivity
and treatment charges. Acknowledging the high relapse rate from
conventional treatment, Dr. Susan Blumenthal, a women's health
specialist in the Department of Health and Human Services, said, "Of
course, any new modalities would be welcome."

Some studies from the former Soviet Union and China have pointed to
acupuncture as a possibly effective method for treating mood disorders.
But depression per se doesn't exist as a diagnosis in traditional
Chinese medicine, says psychologist John Allen of University of Arizona,
Tucson. "We decided to look at how well acupuncture worked in treating
the various symptoms of depression, even though the Chinese don't have a
specific name for the illness," he says. With Tucson acupuncturist Rosa
Schnyer, Allen did a 16-week experiment to test the value of acupuncture
treatments tailored for improving specific symptoms of 34 seriously
depressed women.

The study randomly divided the women into three groups. Group 1 got
eight weeks of acupuncture designed to improve each woman's particular
symptoms. Group 2 got eight weeks of general acupuncture, with no effort
to place needles at points linked by Chinese medicine to specific
complaints, followed by eight weeks of treatment tailored to their
problems. Group 3 was put on a wait list for eight weeks to test
improvement just from waiting, then went for eight weeks of acupuncture
prescribed for their own conditions.

"One of the reasons we funded this is because we were so impressed with
the experimental design. It was done with a lot of care," says John
Spencer, senior policy analyst in the U.S. Office of Alternative
Medicine. Right after the study ended, the patients had attained:

* A 43% reduction in symptoms from tailored acupuncture.

* A 22% reduction from the nonspecific acupuncture.

* A 14% reduction just from waiting.

More than half no longer met the criteria for clinical depression after
eight prescribed acupuncture treatments, "and that compares favorably to
therapies we already use, some much more expensive than acupuncture,"
Allen says. These preliminary findings "are very intriguing, certainly
promising enough to justify larger studies," adds Spencer.

But it's still an ongoing study, Allen emphasizes. He's now working on
one-year follow-ups to see how many patients relapse. At least in this
small study, only 12% dropped out.

FISH OIL FOUND EFFECTIVE AGAINST "BIPOLAR DISORDER"

top

Scientists believe they have found a surprising new ally in their
efforts to understand and treat the sharp mood swings of "bipolar
disorder": the fatty acids of fish oil.

A Harvard University clinical trial of 44 patients diagnosed with manic,
or bipolar, depression had such positive results with fish oil that "a
decision was made to stop the trial on ethical grounds" after four
months and all patients were put on a treatment of 14 capsules per day.

"The group taking the fish oil was performing strikingly better than the
placebo group, including significantly longer periods of remission,"
said Andrew L. Stoll, director of the Psychopharmacology Research
Laboratory at Harvard Medical School/McLean Hospital.

Fish oil is especially high in omega-3 fatty acids, a family of
long-chained polyunsaturated fats that have been associated with reduced
cardiovascular disease and other health benefits.

In recent years, clinical investigators in many parts of the world have
all found a deficit of Omega-3 essential fatty acids in depressed
patients--accompanied by high levels of Omega-6 essential fatty acids
and saturated ("hard") fatty acids.

Sixteen patients were in the placebo group and over the period nine of
these had a major relapse. 14 patients were taking EPA and only one of
these relapsed. On every other rating scale the EPA group did better
than the placebo group. The results on depression were particularly
clear-cut.

In the study, Stoll gave patients 10 grams of fish oil fatty acids a
day, an extremely high dose. The capsules contained eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA), the two primary molecules of
the omega-3 family. There were only minor side effects--some gastric
trouble and diarrhea--which he said were easily controlled.

The study was published in the May 1999 issue of the Archives of General
Psychiatry.

Stoll said he stumbled across fish oil as a possible treatment of manic
depression when he surveyed the literature on compounds with effects
similar to traditional drugs such as lithium and valproate. "Everywhere
we looked, we came up with omega-3s," he said. "I had heard about
omega-3s in medical school, but there hadn't been a lot of attention
paid to them since."

Essential fatty acids must be consumed in the diet or as supplements
because the body cannot make them. A major dietary source of omega-3 is
fatty fish such as mackerel, Atlantic salmon, bluefish, halibut,
herring, and Sockeye salmon. People seeking to increase their
consumption of omega-3 fatty acids can also eat green leafy vegetables,
nuts, flaxseed and canola oils, which contain fatty acids that the body
can make into two chemicals, called EPA and DHA, that are thought to
produce the health benefits.

There is so much saturated fat and so little Omega-3 fatty acids in the
typical diet that getting the right balance can be a challenge. Direct
supplementation of the diet with appropriate fish oils is the easiest
approach.

A larger follow-up fish oil study is now underway. In reference to this
new study at Baylor, Jerry Cott, chief of the NIH psychopharmacology
research program, said:

"This is the first time we would be testing a nutritional supplement
that appears to be having efficacy about to the degree of a synthetic
medication. This could give us real insight into what is the basis of
this psychiatric disorder... Right now, we have no clue what it's
really about."

Billions are spent every year on the pharmaceutical "management" of mood
disorders -- such as using lithium to "even out the mood swings between
high and low" -- because no cure has been available in psychiatric
circles.

MOOD-ALTERING DRUGS AND EDUCATIONAL PERFORMANCE

top

Despite escalating use of Ritalin and similar drugs on school-age and
even preschool children in recent years, the long-term effects of
mood-altering drugs on educational performance have never been assessed.
Most studies have followed kids for only a few weeks, and were intended
to test how well treatments worked in easing ADHD symptoms. The largest
and longest study to date, published in 1999, lasted only 14 months and
addressed the alleviation of symptoms of ADHD using Ritalin as compared
to behavioral therapy.

However, research is now yielding some long-term data on whether Ritalin
and related drugs are actually helping ADHD-diagnosed children. In 1999,
a study by William Frankenberger and Christine Cannon at the Human
Development Center at the University of Wisconsin in Eu Claire found
that 13 "ADHD" children on medication performed progressively worse over
4 years on standardized tests when compared with a group of 13 normal
children with similar IQs and other characteristics.

Additionally, preliminary research by Gretchen LeFever, an assistant
professor of pediatrics and psychiatry at Eastern Virginia Medical
School, found that, although the children in her southeastern Virginia
community use the drug Ritalin 2 to 3 times more than the national rate,
the medication is not improving "ADHD" kids' academic performance in
relation to their peers. LeFever is currently conducting further
research to look for ways to get real results on these children. The
project, called Promoting Responsible Actions Through Intervention in
School-wide Education, will train parents and school personnel to create
consistent tactics for dealing with "problem children." It will also
assess how well those tactics work in improving the educational outcomes
of "ADHD" kids over time.

While both studies are small and require further validation, it is
already apparent that there is a wide gap between the clinical trials of
mood-altering drugs that report favorable results and their actual use
in a community setting.

CONNECTICUT BILL FORBIDS SCHOOLS TO PROMOTE RITALIN

top

Connecticut school personnel can no longer recommend that children take
Ritalin or other mood-altering drugs. A bill that unanimously passed the
state House in May 2001 prohibits it.

House members voted 141-0 to approve the bill, which now goes to the
state Senate.

The bill is a reaction to what critics say is the over-prescription of
mood-altering drugs, including powerful anti-depressants like Prozac and
Zoloft, to children. The drugs are used most often to treat "attention
deficit disorder," which critics say is over-diagnosed.

State Rep. Lenny Winkler, R-Groton, one of the bill's primary sponsors,
quoted studies showing the number of children taking Ritalin, one of the
most common drugs, jumped from 500,000 in 1987 to more than 6 million
today. An emergency room nurse, Winkler said she's "horrified" at the
list of mood-altering drugs taken by some children admitted to the
hospital.

Winkler said there is strong anecdotal evidence that school personnel
recommending the drugs to parents has contributed to their
over-prescription.

The school's suggestion causes parents to bring up the idea to doctors
who often prescribe the drugs based at least partly on the school's
recommendation, she said.

Under the bill, school personnel could still recommend that a child
undergo testing. With the permission of a parent, school officials could
also still consult with medical personnel about a child's case.

"You can recommend that an evaluation be done," Winkler said. "[Whether
to prescribe drugs] is the physician's final decision."

State Rep. Cameron C. Staples, D-New Haven, co-chairman of the
legislature's Education Committee, said in support of the bill, "This is
essentially saying if you're not a health professional, you shouldn't be
recommending that a child take a psychotropic drug," Staples said. "It's
almost common sense."

The bill also prohibits the state Department of Children and Families
from using a parent's decision not to put their child on mood-altering
drugs as a basis for taking away the child.

NEUROLOGICAL IMPACT OF FLUORIDE TOXICITY

top

While the links from fluoride consumption to cancer, osteoporosis, and
other physical ailments are long established, recently studies have
shown that fluoride impact is much broader and includes neurological and
cerebrovascular effects.

Fluoride has been banned in Sweden, Norway, Denmark, West Germany (now
unified), Italy, Belgium, Austria, France, and The Netherlands.

Tea (not including the herbal varieties) is a surprising culprit, in
addition to fluoridated drinking water supplies and fluoride
toothpaste.

A 52-week study of the factors that enhance or inhibit the
bioavailability of aluminum and its effects on the nervous system was
published in 1998 in the Journal of Brain Research. According to the
report, the equivalent of fluoridated drinking water in terms of
elemental fluorine levels had an impact on brain tissue similar to the
pathological changes found in humans with Alzheimer's and other forms of
dementia.

The introduction to the report noted, "One of their most remarkable
findings was that animals administered the lowest dose of
aluminum-fluoride (0.5 ppm) exhibited a greater susceptibility to
illness and a higher incidence of mortality than the animals
administered the higher levels (5 ppm, 50 ppm) of aluminum [without the
fluoride].

"While the small amount of aluminum-fluoride in the drinking water of
rats required for neurotoxic effects is surprising, perhaps even more
surprising are the neurological results of the sodium-fluoride at the
dose given in the present study (2.1 ppm) [the amount used to achieve
1 ppm of elemental fluorine used in fluoridation].

"In most reports of chronic fluoride toxicity, the data provided are
usually limited to weight loss, dental and skeletal changes,
indicators of carcinogenesis, and damage to soft tissues.

"Fluoride has diverse actions on a variety of cellular and
physiological functions, including the inhibition of a variety of
enzymes, a corrosive action in acid mediums, hypocalcemia [low blood
calcium], hyperkalemia [excess blood potassium], and possibly cerebral impairment."

The authors summarize, "Chronic administration of aluminum-fluoride and
sodium-fluoride in the drinking water of rats resulted in distinct
morphological alterations of the brain, including the effects on neurons
and cerebrovasculature."

A previous study by Mullenix, et al. in Neurotoxicology and Teratology,
1995, documents abnormal behavioral responses by animals exposed to
fluoride at various stages of gestation, which resulted in permanent
hyperactivity if exposed prenatally, or extreme lethargy if exposed
after birth, with some animals not able to find their way out of a
circular maze to the same food source every day.

This study of the neurological effects of sodium fluoride, which is
commonly touted as a safe and even health-promoting drinking water
additive, came on the heels of a recent report in the Journal of the
American Medical Association that 2 million people a year become ill,
and more than 100,000 die, from medicines judged by the medical
community to have been "correctly prescribed and correctly
administered."

The fluoride/aluminum association is of particular importance as it
relates to Alzheimer's Disease. Aluminum by itself is not readily
absorbed by the body. However, fluoride ions combine with aluminum to
form aluminum fluoride, which is absorbed by the body. In the body, the
aluminum eventually combines with oxygen to form aluminum oxide or
alumina. Protein bound to alumina in afflicted brains forms the plaques
and tangles characteristic of Alzheimer's disease.

In a study by Dr. Robert Isaacson at the State University of New York,
aluminum fluoride was added to rats' diet. This, contrary to normal
expectations, passed through the brain barrier and gave the rats
short-term memory loss, smell sensory loss, unsteady gait, and loss of
structures of the neo-cortex and hippocampus, all symptoms of
Alzheimer's. A Varner and Jensen study conducted with Isaacson confirmed
this in 1998.

B-12 AND FOLATE CAN REDUCE ALZHEIMERS RISK

top

Elderly people with low blood levels of vitamin B-12 and folic acid
(folate) may face an increased risk of developing Alzheimer's disease.
Vitamin B-12 plays an important role in maintaining nerve cells, and
some research has linked low blood levels of the vitamin to Alzheimer's
and mental decline. Few studies have looked at whether there is such a
connection between Alzheimer's and folate, a B vitamin key to the
production and maintenance of body cells.

The May 8, 2001, issue of Neurology reports on a study of 370
individuals aged 75 and older, in which investigators found that those
with low levels of either vitamin were twice as susceptible to
Alzheimer's over a 3-year period as those with normal levels. The link
was even stronger among study participants who performed well on mental
tests at the start of the study.

The reason for the link is unclear, but low blood levels of B-12 and
folate can lead to elevations in the amino acid homocysteine, which may
in turn damage nerve cells, the authors note. Vitamin B-12 is found in
meat, fish, eggs, and milk. Vegetarians are advised to supplement their
B-12 intake. Folate occurs naturally in leafy green vegetables, dried
beans and peas, and citrus fruits, among others. Many cereals are
fortified with folic acid, the synthetic form of folate.

Alzheimer's is the most common form of dementia, affecting an estimated
4 million Americans. The exact cause remains elusive, but scientists
believe genetics and environmental factors conspire to trigger the onset
of the disease.

The May 8, 2001 issue of Neurology Magazine listed the following as
warning signs of Alzheimer's Disease: memory loss that affects job
skills; language problems; difficulty performing familiar tasks;
misplacing objects; changes in mood and behavior; poor judgment;
disorientation as to time and place; personality changes; problems with
abstract thinking; and loss of initiative.

Brain imaging is recommended to help rule out other causes of memory
loss or dementia. This includes computed tomography (CT) and magnetic
resonance imaging (MRI). Genetic testing has not been found particularly
useful. [Annual Meeting of the American Academy of Neurology, 2001]

The elderly are not the only ones that need to worry about B-12.
According to one practitioner, the most common cause of B-12 deficiency
is a vegetarian diet.

The drug Prilosec (omeprazole) has been shown to decrease B-12
absorption [Annual of Pharmacotherapy, May 1999]. This is possibly due
to its effects on decreasing the production of intrinsic factor, which
is needed for proper B-12 absorption. Other medications may have similar
adverse effects.

There is also little question now that B-12 and folic acid are useful to
reduce homocysteine and the associated increase in heart disease and
birth defects.

IS IT DEPRESSION, OR CHRONIC FATIGUE SYNDROME?

top

Although Chronic Fatigue Syndrome (CFS) is not a mental health problem,
it is frequently treated with psychotropic drugs.

This is the result of two factors. First, many of the symptoms exhibited
with CFS (such as anxiety, depression, and sleep disorders) have led to
misdiagnosis by doctors not fully familiar with CFS, and, second, even
when properly diagnosed, the tendency is to treat CFS symptomatically,
as its cause is unknown.

Per the National Institutes of Health, doctors are now using low-dose
tricyclic antidepressants, serotonin reuptake inhibitors, and
benzodiazepines (a class of drugs used to treat acute anxiety and sleep
problems) to treat CFS. Success in symptomatic relief with illnesses
similar to CFS (such as fibromyalgia) led to the idea that the symptoms
of CFS could be likewise treated.

The symptoms of CFS include the above, but clinical diagosis is also
dependant upon other factors.

Co-Cure, an information exchange facility for those interested in or
suffering from CFS, Fibromyalgia and related disorders, describe CFS as
follows:

"Chronic fatigue syndrome (CFS) is an emerging illness characterized
by debilitating fatigue (experienced as exhaustion and extremely poor
stamina), neurological problems, and a variety of flu-like symptoms.
The illness is also known as chronic fatigue immune dysfunction
syndrome (CFIDS), and outside of the USA is usually known as myalgic
encephalomyelitis (ME). In the past the syndrome has been known as
chronic Epstein-Barr virus (CEBV).

"The core symptoms include excessive fatigue, general pain, mental
fogginess, and often gastro-intestinal problems. Many other symptoms
will also be present, however they will typically be different among
different patients. These include: fatigue following stressful
activities; headaches; sore throat; sleep disorder; abnormal
temperature; and others.

"The degree of severity can differ widely among patients, and will
also vary over time for the same patient. Severity can vary between
getting unusually fatigued following stressful events, to being
totally bedridden and completely disabled. The symptoms will tend to
wax and wane over time. This variation, in addition to the fact that
the cause of the disease is not yet known, makes this illness
difficult to diagnose."

Additionally, it has been observed that cognitive dysfunction often
increases over several years, and that brain scans often show decreased
blood flow to the brain.

Although the cause of CFS is not known, it has been closely linked to
allergies, candida, environmental pollutants, mercury toxicity,
artificial sweeteners (especially aspartame - found in such products as
Nutri-sweet and Equal), and glutamate (found in MSG and other
excitotoxins).

A doctor experienced with CFS and up to date on research into the area
can assist individuals with diagnosis and drug-free treatment.

ORTHOMOLECULAR SUPPORTERS HOLD TORONTO EVENT

top

The Canadian Schizophrenia foundation is an organization dedicated to
the orthomolecular (nutritional) treatment of people classified with
schizophrenia. On May 4, 2001 Robert Sealey, BSc, a Toronto consultant
and writer, coordinated a fundraising event for the Foundation in the
Concert Hall of the Royal York Hotel in Toronto at the 30th conference
of the International Society of Orthomolecular Medicine.

Sealy is the founder of FOR*OM - a network of Friends of Restorative
Orthomolecular Medicine. The event drew a crowd of 300 people and raised
$6,000 for orthomolecular research and public education.

The event hosted six former mental patients who have been helped by
restorative orthomolecular medicine for mood disorders, schizophrenia,
autism, and other conditions. The seventh speaker was actress Margot
Kidder, probably one of the most famous success stories today of one who
has recovered through nutritional treatment.

The success stories of six other patients and six health professionals
(who use orthomolecular medicine in their practices) were then presented
in a screening of the 1998 TV documentary Masks of Madness - Science of
Healing.

A tape of this event is available from the Foundation at

16 Florence Ave.
Toronto, ON, Canada, M2N 1E9.
Ph 416-733-2117

e-mail: centre@orthomed.org
website: www.orthomed.org

ABOUT AlternativeMentalHealth.com

top

ALTERNATIVEMENTALHEALTH.COM IS THE WORLD'S LARGEST WEB SITE DEVOTED
exclusively to alternative mental health treatments. It includes a
directory of over 180 physicians, nutritionists, experts, organizations,
and facilities around the U.S. that offer or promote safe, alternative
treatments for severe mental symptoms. Many of the physicians listed do
in-depth examinations to find the physical causes behind mental
problems.

Also included on the site are an array of articles on topics ranging
from the medical causes of schizophrenia to the effects of toxic metals
on mental health.

A bookstore page lists top books that cover many areas of alternative
treatments with titles like Natural Healing for Schizophrenia and Other
Common Mental Disorders and No More Ritalin.

AlternativeMentalHealth.com has been created to educate the public,
practitioners, and government officials on the medical conditions that
create "mental illness" and the many safe resources available for
addressing and often curing severe mental symptoms.